A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up. We report a case treated with 50 mg long-acting risperidone administered every 14 days, who has been followed-up for three years. We studied his regional cerebral blood flow through technetium-99 m hexamethylpropyleneamine oxime single-photon emission computed tomography after two years of treatment. Symptoms of catatonic schizophrenia improved after two months of treatment, followed suit by oneiroid syndrome remission. Two years later, his brain perfusion was normal. No side effect has occurred since the patient was started on long-acting risperidone. Long-acting risperidone proved to be safe and effective in treating symptoms of catatonia and oneiroid syndrome.

Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome / Serata, Daniele; Rapinesi, Chiara; Demetrios Kotzalidis, Georgios; Chiara Alessi, Maria; Janiri, Delfina; Claudia Massolo, Anna; Rachele Ferri, Vittoria; Criscuolo, Silvia; Callovini, Gemma; Angeletti, Gloria; Girardi, Paolo; DEL CASALE, Antonio. - In: THE INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE. - ISSN 0091-2174. - STAMPA. - 50:3(2015), pp. 251-256. [10.1177/0091217415610512]

Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome

SERATA, DANIELE;RAPINESI, CHIARA;JANIRI, DELFINA;ANGELETTI, Gloria;GIRARDI, Paolo;DEL CASALE, ANTONIO
2015

Abstract

A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up. We report a case treated with 50 mg long-acting risperidone administered every 14 days, who has been followed-up for three years. We studied his regional cerebral blood flow through technetium-99 m hexamethylpropyleneamine oxime single-photon emission computed tomography after two years of treatment. Symptoms of catatonic schizophrenia improved after two months of treatment, followed suit by oneiroid syndrome remission. Two years later, his brain perfusion was normal. No side effect has occurred since the patient was started on long-acting risperidone. Long-acting risperidone proved to be safe and effective in treating symptoms of catatonia and oneiroid syndrome.
2015
Schizophrenia; catatonia; intellectual disability; long-acting; oneiroid state; risperidone; single-photon emission computed tomography (SPECT)
01 Pubblicazione su rivista::01a Articolo in rivista
Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome / Serata, Daniele; Rapinesi, Chiara; Demetrios Kotzalidis, Georgios; Chiara Alessi, Maria; Janiri, Delfina; Claudia Massolo, Anna; Rachele Ferri, Vittoria; Criscuolo, Silvia; Callovini, Gemma; Angeletti, Gloria; Girardi, Paolo; DEL CASALE, Antonio. - In: THE INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE. - ISSN 0091-2174. - STAMPA. - 50:3(2015), pp. 251-256. [10.1177/0091217415610512]
File allegati a questo prodotto
File Dimensione Formato  
Serata_Effectiveness_2015.pdf

solo gestori archivio

Tipologia: Documento in Pre-print (manoscritto inviato all'editore, precedente alla peer review)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 157.97 kB
Formato Adobe PDF
157.97 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/832687
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact